Asensus Surgical, Inc. (ASXC)
Aug 22, 2024 - ASXC was delisted (reason: acquired by KARL STORZ)
0.350
0.00 (0.00%)
Inactive · Last trade price on Aug 21, 2024

Asensus Surgical Statistics

Total Valuation

ASXC has a market cap or net worth of $94.92 million. The enterprise value is $92.26 million.

Market Cap 94.92M
Enterprise Value 92.26M

Important Dates

The last earnings date was Tuesday, August 13, 2024, after market close.

Earnings Date Aug 13, 2024
Ex-Dividend Date n/a

Share Statistics

ASXC has 272.84 million shares outstanding. The number of shares has increased by 11.67% in one year.

Current Share Class n/a
Shares Outstanding 272.84M
Shares Change (YoY) +11.67%
Shares Change (QoQ) +1.13%
Owned by Insiders (%) 2.05%
Owned by Institutions (%) 9.75%
Float 245.79M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.38
Forward PS 3.71
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 9.37
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.49

Current Ratio 0.49
Quick Ratio 0.21
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -221.88

Financial Efficiency

Return on equity (ROE) is -334.02% and return on invested capital (ROIC) is -146.49%.

Return on Equity (ROE) -334.02%
Return on Assets (ROA) -76.18%
Return on Capital (ROIC) -146.49%
Revenue Per Employee $47,129
Profits Per Employee -$400,952
Employee Count 209
Asset Turnover 0.17
Inventory Turnover 1.58

Taxes

In the past 12 months, ASXC has paid $356,000 in taxes.

Income Tax 356,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +25.54% in the last 52 weeks. The beta is 1.38, so ASXC's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change +25.54%
50-Day Moving Average 0.33
200-Day Moving Average 0.29
Relative Strength Index (RSI) 63.19
Average Volume (20 Days) 2,974,986

Short Selling Information

The latest short interest is 11.29 million, so 4.14% of the outstanding shares have been sold short.

Short Interest 11.29M
Short Previous Month 11.32M
Short % of Shares Out 4.14%
Short % of Float 4.59%
Short Ratio (days to cover) 7.11

Income Statement

In the last 12 months, ASXC had revenue of $9.85 million and -$83.80 million in losses. Loss per share was -$0.32.

Revenue 9.85M
Gross Profit -3.00M
Operating Income -71.22M
Pretax Income -78.44M
Net Income -83.80M
EBITDA -67.47M
EBIT -71.22M
Loss Per Share -$0.32
Full Income Statement

Balance Sheet

The company has $7.78 million in cash and $5.12 million in debt, giving a net cash position of $2.66 million or $0.01 per share.

Cash & Cash Equivalents 7.78M
Total Debt 5.12M
Net Cash 2.66M
Net Cash Per Share $0.01
Equity (Book Value) -11.33M
Book Value Per Share -0.04
Working Capital -20.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.65 million and capital expenditures -$506,000, giving a free cash flow of -$57.16 million.

Operating Cash Flow -56.65M
Capital Expenditures -506,000
Free Cash Flow -57.16M
FCF Per Share -$0.21
Full Cash Flow Statement

Margins

Gross Margin -30.45%
Operating Margin -723.08%
Pretax Margin -847.14%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -697.89%

Dividends & Yields

ASXC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.67%
Shareholder Yield -11.67%
Earnings Yield -88.28%
FCF Yield -60.21%

Analyst Forecast

Price Target $0.35
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 2
Revenue Growth Forecast (5Y) 79.18%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 12, 2019. It was a reverse split with a ratio of 0.076923:1.

Last Split Date Dec 12, 2019
Split Type Reverse
Split Ratio 0.076923:1

Scores

ASXC has an Altman Z-Score of -41.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -41.46
Piotroski F-Score 3